Hexagon Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Hexagon Capital Partners's LLY Position: Q2 2026 in Review
Hexagon Capital Partners increased its Eli Lilly (LLY) stake by 7% in Q2 2026, buying an estimated $78.7K and bringing the position to 1,184 shares worth $1.42M. The position accounts for 0.2% of the portfolio, ranked #53.
Hexagon Capital Partners first reported a position in LLY in Q3 2020 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hexagon Capital Partners held 1,184 shares of Eli Lilly worth $1.42M as of Q2 2026.
- Hexagon Capital Partners bought 77 Eli Lilly shares in Q2 2026, an estimated $78.7K.
- Eli Lilly made up 0.2% of Hexagon Capital Partners's portfolio in Q2 2026, its #53 holding.
- Hexagon Capital Partners first reported a position in Eli Lilly in Q3 2020 and has held it in 21 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.